You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Scleroderma
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:scleroderma [01.19.2019] – [Recent research] sallieqhome:diseases:scleroderma [01.19.2019] – [interview] sallieq
Line 21: Line 21:
 http://www.ncbi.nlm.nih.gov/pubmed/19758208 http://www.ncbi.nlm.nih.gov/pubmed/19758208
 </blockquote> </blockquote>
 +
 +Hypodermitis sclerodermiformis. Successful treatment with ultrasound.  (({{pubmed>long:7082022}}))  
  
 ===== A Guide to Antibiotic Therapy ===== ===== A Guide to Antibiotic Therapy =====
Line 61: Line 63:
 This capillaroscopic score may represent a feasible and simple tool in SSc patients' assessment. The routinely use of this parameter might permit to recognize and to preventively treat SSc patients at high risk to develop digital ulcers.  (({{pubmed>long:18854881}}))   This capillaroscopic score may represent a feasible and simple tool in SSc patients' assessment. The routinely use of this parameter might permit to recognize and to preventively treat SSc patients at high risk to develop digital ulcers.  (({{pubmed>long:18854881}}))  
  
-===== Patient =====+===== Interview =====
  
  
Line 88: Line 90:
  
 Interviews of patients with other diseases are [[home:patients:patient_interviews|also available]]. Interviews of patients with other diseases are [[home:patients:patient_interviews|also available]].
 +
 +===== Patient =====
 +
  
 {{tag>disease arrange}} {{tag>disease arrange}}
home/diseases/scleroderma.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.